(Q73141412)
Statements
The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA (English)
A Magklara
A Scorilas
W J Catalona
E P Diamandis
1 November 1999